Search
for
Sort by
Research 301–330 of 1000+
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Treatment of Hair Loss
- Medical complications of anorexia nervosa and bulimia nervosa
- The Rotterdam Study: 2018 update on objectives, design and main results
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- The Rotterdam Study: 2016 objectives and design update
- Mucocutaneous reactions to chemotherapy
- Polycystic Ovary Syndrome
- Melatonin in the skin: synthesis, metabolism and functions
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Evaluation and treatment of male and female pattern hair loss
- ATP-dependent chromatin remodeling during mammalian development
- Endocrinology of Transgender Medicine
- Low‐level laser (light) therapy (LLLT) for treatment of hair loss
- Decreased Serum Ferritin is Associated With Alopecia in Women
- Theoretical considerations in laser hair removal
- Hormone therapy for transgender patients
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- The Role of Vitamins and Minerals in Hair Loss: A Review
- Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
- Severe Acute Respiratory Syndrome Among Children
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Nutrition and Hair
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Polycystic Ovary Syndrome
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Safety of testosterone treatment in postmenopausal women